Dr. Shao received his Ph.D. degree from Peking Union Medical College (PUMC), China, and has been at the Laboratory of Molecular Pharmacology, National Cancer Institute/NIH, USA from 1994 to 1999. Dr. Shao was the former Director of Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences (CAMS), Beijing. Dr. Shao is also the Chair Professor of Cheung-Kong Scholars of PUMC supported by the Ministry of Education, China. Dr. Shao has received the Paul Janssen Pharmaceutical Research Award and Outstanding Contribution Expert Awarded by the Ministry of Health, and the National Outstanding Scientist Award for his role in the investigating function of signaling molecules as targets for cancer therapy and the research and development of anticancer drugs. He serves as Vise-Editors of Acta Pharmaceutica Sinica B, Chinese Journal of Antibiotics, Chinese Medical Biotechnology and Chinese Journal of Biochemical Medicine. He also served as Director of Society of Antibiotics (Chinese Pharmaceutical Association) and Emeritus Directors including Society of Anticancer Agents (China Anti-Cancer Association), Society of Cancer Pharmacology (Chinese Pharmacological Society) and Deputy Director of Society of Monoclonal Antibody (China Med-Biotech Association). The research works focus on Molecular pharmacology, anticancer drug, translational medicine, programmed cell death, autophagy, cellular signaling transduction and cell cycle regulation. Dr. Shao has authored over 200 publications and edited in chief 6 books, and holds over 20 patents.